Materials • Major Chemicals
$2.13 ▲ +0.10
(+4.93%)
MKT CAP: $326.5M • VOL: 3.81M
52W L $2 52W H $10
ASPI // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $23.8M | $4.1M | $433.0K |
| YoY Revenue Growth % | +475.5% | +857.0% | — |
| Gross Profit | $3.4M | $1.6M | — |
| Gross Margin % | 14.3% | 38.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$59.9M | -$26.4M | -$16.0M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$159.8M | -$32.4M | -$16.3M |
| EBITDA (Normalized) | -$52.2M | -$18.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$37.8M | -$16.7M | -$5.4M |
| Capital Expenditures (CapEx) | $9.7M | $9.7M | — |
| Free Cash Flow (FCF) | -$47.4M | -$26.4M | -$5.4M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $279.6M | $61.9M | — |
| Total Debt (Short + Long Term) | $1.5M | $1.4M | — |
| Total Stockholders' Equity | $204.2M | $47.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ASPI.